Hints and tips:
...Before Alere, Mr Nawana spent more than 15 years at Johnson & Johnson, including time as president of its DePuy Synthes spine business....
...A V-shaped recovery in kneecaps isn’t in the price, they say....
...Still, orthopaedics is largely a consolidation story. DePuy Synthes was created following Johnson & Johnson’s $21.3bn takeover of Switzerland’s Synthes in 2012....
...A number of clinician-led clinics are also growing, such as one by Fortius, a specialist in orthopaedic and sports injuries....
...The recession has made life even tougher for the family, says Mr Mendes Machado, who earns a commission from selling orthopaedic mattresses....
...A day after surgery, the hospital says, the patient was eating and speaking again....
...It valued the orthopaedic devices maker at £12.25 on a standalone basis, with a further 200p to 250p possible from M&A....
...It found that HCA accounted for more than 60 per cent of private cancer care, orthopaedics, obstetrics and gynaecology, and gastrointestinal medicine in the capital....
...The company took unspecified litigation charges, against a backdrop of continuing legal actions including compensation demands from users of its DePuy ASR artificial hip....
...Shares in medical device makers and hospitals tanked on Friday after news that a Florida Medicare administrator would audit patients’ medical records before paying for certain costly cardiovascular and orthopaedic...
...cardiovascular and orthopaedic conditions from the start of the new year....
...DePuy, the division of J&J that Synthes would potentially join, made revenues of $5.6bn but supposedly lower profitability....
...Jude, Boston Scientific) underperforming badly while orthopaedic specialists (Stryker, Smith & Nephew, and Zimmer) have fared better....
...William Weldon, head of J&J, says ringingly of the accord: “DePuy and Synthes together will create the most innovative and comprehensive orthopaedics business in the world, and enable us to better serve...
...It will solidify its dominance in orthopaedics and gain increasing power when dealing with hospitals....
...Results from DePuy, Johnson & Johnson’s orthopaedics division, and Stryker, both highlighted slowing demand for replacement knees, an important product segment for S&N....
...for the US and European orthopaedic markets remains challenging....
...The plot – which was allegedly ordered by a more senior executive – bled money from the country’s taxpayers by inflating the price of orthopaedic products sold to the health system....
...Mr Dougall was released on bail by City of Westminster magistrates’ court after being charged with conspiring with DePuy between 2002 and 2005 to pay bribes to entice Greek health officials to buy orthopaedic...
...Smith & Nephew dropped 3.2 per cent to 532p after Johnson & Johnson, owner of DePuy Orthopaedics, posted weaker-than-expected quarterly sales....
...Leeds NHS Teaching Hospitals Trust is the largest trust in the UK, and includes the largest teaching hospital in Europe with an annual budget of £540m....
...In the case, Zimmer and four other companies – Depuy, Biomet, Stryker of the US and Smith & Nephew of the UK – were accused of paying large sums of money to surgeons as well as giving them trips and expensive...
...He devised a new kind of hospital bed and various power saws for cutting bone, before inventing assorted prosthetic devices....
...In late July, KKR teamed up with Bain Capital and Merrill Lynch to buy HCA, the largest US hospitals chain, for $33bn including debt, in one of the largest leveraged buy-outs ever....
...But according to Martin Stone, consultant surgeon at Chapel Allerton Hospital Orthopaedic Centre in Leeds, “Newer hips are inevitably more expensive and we’re not going to see the frontiers pushed forward...
International Edition